Regulatory News: Amplitude Surgical SA (Paris:AMPLI): Following the joint announcement of March 11, 2025, Zydus Lifesciences Limited ("Zydus") and Amplitude Surgical SA (Paris:AMPLI) ("Amplitude") ...

India supplies over 45% of the generics and 15% of biosimilars used in the U.S., with major companies like Dr. Reddy’s, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma, and Gland Pharma earning ...

Divi’s Laboratories, Zydus Lifesciences and Tata Consultancy Services will be some of the other stocks to watch before going ...

Zydus Medtech & Braile Biomedica of Brazil enter global licensing pact to commercialise TAVI technology: Our Bureau, Mumbai Saturday, April 19, 2025, 13:30 Hrs [IST] Zydus MedTech ...

Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited on Friday entered into a strategic partnership with Braile Biomédica Indústria, Comércio e Representações Ltda., ...

Indian pharmaceutical giant Zydus Lifesciences has a lost patent battle with Tokyo-based Astellas Pharma. The US District ...

Zydus Lifesciences Limited announces the execution of undertakings from 7 shareholders to tender 2,236,911 Amplitude Surgical ...

Zydus MedTech has partnered with Brazil-based Braile Biomedica to commercialize innovative TAVI technology across Europe, ...

A U.S. District Court recently ruled against Zydus and Lupin, finding Astellas's patent for Myrbetriq was not invalid. Both ...

The litigation was initiated by Astellas Pharma against Zydus Lifesciences concerning the validity of the ‘780 patent’, which ...

Ahmedabad: Zydus Lifesciences Limited has announced the execution of undertakings from 7 shareholders to tender 2,236,911 ...